Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma: A review

Journal of Neurosurgery: Pediatrics

Volumn 10, Issue 3, 2012, Pages 175-181

  Jabbour, Pascal ^a   Chalouhi, Nohra ^a   Tjoumakaris, Stavropoula ^a   Gonzalez, L Fernando ^a   Dumont, Aaron S ^a   Chitale, Rohan ^a   Rosenwasser, Robert ^a   Bianciotto, Carlos G ^b   Shields, Carol ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Intraarterial chemotherapy; Melphalan hydrochloride; Oncology; Ophthalmic artery; Retinoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; MELPHALAN; VINCRISTINE;

BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CATARACT; CYTOPENIA; DRUG TREATMENT FAILURE; DRY EYE; ENUCLEATION; EVENT FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FACE DYSMORPHIA; FAILURE TO THRIVE; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; LEUKEMIA; LEUKOKORIA; METASTASIS; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; OTOTOXICITY; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; SYSTEMIC THERAPY; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR REGRESSION; TUMOR SEEDING; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS, ALKYLATING; EYE ENUCLEATION; HUMANS; INJECTIONS, INTRA-ARTERIAL; MELPHALAN; NEOPLASM SEEDING; OPHTHALMIC ARTERY; RESEARCH DESIGN; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 84865985477     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2012.5.PEDS1277     Document Type: Review

References (47)

1. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP: A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115:1398-1404, 1404 e1, 2008
2. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP: Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol 128:370-372, 2010
3. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP: Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117:1623-1629, 2010
4. Bayar E, Robinson MG, Kurczynski TW: Unilateral retinoblastoma with acquired monosomy 7 and secondary acute myelomonocytic leukemia. Cancer Genet Cytogenet 105:79-82, 1998
5. Benz MS, Scott IU, Murray TG, Kramer D, Toledano S: Complications of systemic chemotherapy as treatment of retinoblastoma. Arch Ophthalmol 118:577-578, 2000
6. Bianciotto C, Shields CL, Iturralde JC, Sarici A, Jabbour P, Shields JA: Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma. Ophthalmology 119: 843-849, 2012
7. Broaddus E, Topham A, Singh AD: Survival with retinoblastoma in the USA: 1975-2004. Br J Ophthalmol 93:24-27, 2009
8. Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R: Retinoblastoma: review of current management. Oncologist 12:1237-1246, 2007
9. De Potter P, Shields CL, Shields JA: Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus 31:26-31, 1994
10. De Potter P, Shields CL, Shields JA, Singh AD: Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol 112:208-212, 1994
11. Doz F: [Retinoblatoma: a review.] Arch Pediatr 13:1329-1337, 2006 (Fr)
12. Dunkel IJ, Lee TC, Shi W, Beaverson KL, Novetsky D, Lyden D, et al: A phase II trial of carboplatin for intraocular retinoblastoma. Pediatr Blood Cancer 49:643-648, 2007
13. Eagle RC Jr, Shields CL, Bianciotto C, Jabbour P, Shields JA: Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol 129:1416-1421, 2011
14. Ferris FL III, Chew EY: A new era for the treatment of retinoblastoma. Arch Ophthalmol 114:1412, 1996
15. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH: Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 129:732-737, 2011
16. Greenwald MJ, Strauss LC: Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology 103:1989-1997, 1996
17. Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, et al: The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol 116:1613-1617, 1998
18. Imhof SM, Mourits MP, Hofman P, Zonneveld FW, Schipper J, Moll AC, et al: Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology 103: 263-268, 1996
19. Inomata M, Kaneko A: Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res 78:858-868, 1987
20. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN: Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114:1339-1343, 1996
21. Kiss S, Leiderman YI, Mukai S: Diagnosis, classification, and treatment of retinoblastoma. Int Ophthalmol Clin 48:135-147, 2008
22. Kivelä T: The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 93:1129-1131, 2009
23. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al: Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23:2272-2279, 2005
24. Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, et al: Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res 11:7569-7578, 2005
25. Linn Murphree A: Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18:41-53, viii, 2005
26. MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, et al: Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol 93:33-37, 2009
27. Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, Binaghi S: Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina 31:566-573, 2011
28. Murphree AL, Villablanca JG, Deegan WF III, Sato JK, Malogolowkin M, Fisher A, et al: Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114:1348-1356, 1996
29. Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA: Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. Clinical article. J Neurosurg 114:1603-1608, 2011
30. Reese AB, Hyman GA, Merriam GR Jr, Forrest AW, Kligerman MM: Treatment of retinoblastoma by radiation and triethylenemelamine. AMA Arch Opthalmol 53:505-513, 1954
31. Rizzuti AE, Dunkel IJ, Abramson DH: The adverse events of chemotherapy for retinoblastoma: what are they? Do we know? Arch Ophthalmol 126:862-865, 2008
32. Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, et al: Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol 129:1407-1415, 2011
33. Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, et al: Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol 129:1399- 1406, 2011
34. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM: Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114:1330-1338, 1996
35. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, et al: Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 133:657-664, 2002
36. Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, et al: Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Ophthalmology 119:188-192, 2012
37. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al: The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276-2280, 2006
38. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA: Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol 138:329-337, 2004
39. Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA: Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina 29:1207-1209, 2009
40. Shields CL, Shields JA: Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17:228-234, 2006
41. Shields CL, Shields JA: Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Experiment Ophthalmol 38:638-643, 2010
42. Shields CL, Shields JA: Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intraarterial chemotherapy. Curr Opin Ophthalmol 21:203-212, 2010
43. Shields CL, Uysal Y, Marr BP, Lally SE, Rodriques E, Kharod B, et al: Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients. Ophthalmology 114:367-373, 2007
44. Suzuki S, Yamane T, Mohri M, Kaneko A: Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology 118:2081-2087, 2011
45. Vajzovic LM, Murray TG, Aziz-Sultan MA, Schefler AC, Fernandes CE, Wolfe SC, et al: Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch Ophthalmol 128:1619-1623, 2010
46. Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA: Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol 128:1427-1431, 2010
47. Yamane T, Kaneko A, Mohri M: The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 9:69-73, 2004